U.S. markets closed

Nutra Pharma Corp. (NPHC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0081+0.0003 (+3.85%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0078
Open0.0079
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0066 - 0.0085
52 Week Range0.0010 - 0.0158
Volume15,861,249
Avg. Volume36,164,145
Market Cap55.527M
Beta (5Y Monthly)3.53
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon
    Newsfile

    Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon

    Nutra Pharma is announcing their newest product, Luxury Feet; is now available for purchase on Amazon.com Plantation, Florida--(Newsfile Corp. - April 15, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that their newest product, Luxury Feet, is available for purchase ...

  • Newsfile

    Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels

    Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos Plantation, Florida--(Newsfile Corp. - March 16, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and ...

  • Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials
    Newsfile

    Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials

    Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation in preparation of expanded OTC sales and clinical trials Plantation, Florida--(Newsfile Corp. - March 11, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) ...